Income Taxes - Schedule of Deferred Tax Assets And Liabilities (Detail) - USD ($) |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Components of Deferred Tax Assets [Abstract] | ||
| Net operating losses | $ 2,850,031 | $ 890,289 |
| Lease liability | 205,630 | 215,272 |
| Capitalized research and development | 2,589,415 | 2,420,060 |
| Research and develpoment credit | 348,597 | 157,265 |
| Stock-based compensation | 18,276 | 20,815 |
| Fixed Asset | 21,887 | 0 |
| Total deferred tax assets | 6,033,836 | 3,703,701 |
| Components of Deferred Tax Liabilities [Abstract] | ||
| ROU asset | (192,565) | (207,413) |
| Fixed Asset | 0 | (246,330) |
| Total deferred tax liabilities | (192,565) | (453,743) |
| Less: valuation allowance | (5,841,271) | (3,249,958) |
| Total | $ 0 | $ 0 |
| X | ||||||||||
- Definition Deferred tax assets fixed assets. No definition available.
|
| X | ||||||||||
- Definition Deferred tax assets lease liabilities. No definition available.
|
| X | ||||||||||
- Definition Deferred tax assets research and develpoment credit. No definition available.
|
| X | ||||||||||
- Definition Deferred tax assets stock based compensation. No definition available.
|
| X | ||||||||||
- Definition Deferred tax liabilities fixed assets. No definition available.
|
| X | ||||||||||
- Definition Deferred tax liabilities right of use assets. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|